News

The Centenary Institute’s Dr Madeleine Gill has today received a National Health and Medical Research Council (NHMRC) postgraduate scholarships grant to continue her research into understanding unexplained heart failure in patients with liver cirrhosis. Cirrhotic cardiomyopathy affects approximately 50 per cent of patients with cirrhosis and can be a barrier to liver transplantation and is ...

Professor Philip Hogg, Head, ACRF Centenary Cancer Research Centre, has featured on Nine News explaining his new theranostics research, recently funded by the Cancer Institute NSW. A form of personalised cancer treatment for the patient, the term ‘theranostics’ refers to a combined therapy and diagnostics approach where tumour markers are employed to deliver a therapeutic isotope ...

Two Centenary Institute scientists have been awarded grants totalling $4.3 million from the Cancer Institute NSW to undertake critical cancer related medical research.

The Centenary Institute has announced it will establish a new precision medicine laboratory, enabling world-leading research into the use of theranostics to treat cancer, thanks to a grant from the Australian Cancer Research Foundation (ACRF).

The Centenary Institute’s Ms Aster Pijning has been awarded the 2021 Thompson Prize by the Australian Society for Biochemistry and Molecular Biology.

Researchers from the Centenary Institute have developed a new approach to fighting melanomas that fail to respond Ð or are resistant Ð to standard treatments.

Aster Pijning, PhD candidate at the ACRF Centenary Cancer Research Centre, has had her science recognised with an image from her paper selected for the recent front cover of the prestigious journal ÔBloodÕ.

Dr Jessamy Tiffen, a senior member of the Centenary InstituteÕs Melanoma Immunology and Oncology Program has some sage advice for aspiring female scientists in advance of this yearÕs ÔInternational Day of Women and Girls in ScienceÕ.

Research led by the Centenary Institute has found that a compound extracted from a commonly cultivated orchid could be a potential new treatment option for prostate cancer.

Professor John Rasko AO, Head of the Gene and Stem Cell Therapy Program at the Centenary Institute spoke recently at an Australian Academy of Science symposium.

The Centenary Institute is pleased to note its involvement in, and support of, the newly announced NSW RNA Production and Research Network involving the stateÕs leading universities and other prominent health and medical research organisations.

Researchers from the Centenary Institute and the Royal Prince Alfred Hospital (RPAH) are co-investigators on three separate liver cancer focused projects that have recently received funding from the Australian GovernmentÕs Medical Research Future Fund (MRFF) and the Cancer Institute NSW.